96 related articles for article (PubMed ID: 16815286)
21. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
22. Gallbladder localization of (19)F MRS catabolite signals in patients receiving bolus and protracted venous infusional 5-fluorouracil.
Dzik-Jurasz AS; Collins DJ; Leach MO; Rowland IJ
Magn Reson Med; 2000 Oct; 44(4):516-20. PubMed ID: 11025505
[TBL] [Abstract][Full Text] [Related]
23. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
[TBL] [Abstract][Full Text] [Related]
24. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
25. The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid).
Shingaki T; Hidalgo IJ; Furubayashi T; Katsumi H; Sakane T; Yamamoto A; Yamashita S
Int J Pharm; 2009 Jul; 377(1-2):85-91. PubMed ID: 19446619
[TBL] [Abstract][Full Text] [Related]
26. Removal rate of 5-fluorouracil and its metabolites in patients on hemodialysis: a report of two cases of colorectal cancer patients with end-stage renal failure.
Imamaki H; Oura M; Oguro F; Nishikawa Y; Nakagawa S; Funakoshi T; Kataoka S; Horimatsu T; Yonezawa A; Matsubara T; Watanabe N; Muto M; Yanagita M; Ozaki Y
Cancer Chemother Pharmacol; 2024 Feb; 93(2):161-167. PubMed ID: 37608127
[TBL] [Abstract][Full Text] [Related]
27. Determination of 5-fluorouracil in plasma with HPLC-tandem mass spectrometry.
van Kuilenburg AB; van Lenthe H; Maring JG; van Gennip AH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1257-60. PubMed ID: 17065102
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of skin sphingosine synthesis: enhanced percutaneous permeation of 5-fluorouracil.
Gupta M; Mahajan A; Babita ; Gupta S; Tiwary AK
Pharmazie; 2004 Mar; 59(3):212-6. PubMed ID: 15074596
[TBL] [Abstract][Full Text] [Related]
29. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
30. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of direct paraffin embedding in cytological analysis of vitreous from proliferative vitreo-retinopathy (PVR)].
Rodríguez De La Rúa E; Martín F; Saornil MA; Fernández N; Pastor JC
Arch Soc Esp Oftalmol; 2001 Nov; 76(11):655-60. PubMed ID: 11715103
[TBL] [Abstract][Full Text] [Related]
32. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
Martino R; Malet-Martino MC; Vialaneix C; Lopez A; Bon M
Drug Metab Dispos; 1987; 15(6):897-904. PubMed ID: 2893719
[TBL] [Abstract][Full Text] [Related]
33. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy.
Hara H; Oh-hashi K; Yoneda S; Shimazawa M; Inatani M; Tanihara H; Kiuchi K
Mol Vis; 2006 Aug; 12():977-82. PubMed ID: 16943769
[TBL] [Abstract][Full Text] [Related]
34. Transthyretin levels in the vitreous correlate with change in visual acuity after vitrectomy.
Van Aken E; De Letter EA; Veckeneer M; Derycke L; van Enschot T; Geers I; Delanghe S; Delanghe JR
Br J Ophthalmol; 2009 Nov; 93(11):1539-45. PubMed ID: 19692381
[TBL] [Abstract][Full Text] [Related]
35. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
36. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
[TBL] [Abstract][Full Text] [Related]
37. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone acetonide concentration after subtenon injection.
Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
[TBL] [Abstract][Full Text] [Related]
39. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
40. Vitreous penetration of orally administered valacyclovir.
Huynh TH; Johnson MW; Comer GM; Fish DN
Am J Ophthalmol; 2008 Apr; 145(4):682-6. PubMed ID: 18226802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
